调整屏幕的大小
Resize out
Resize in
Resize 重置
Done 完成
CureVac - Ingmar Hoerr, CEO

CureVac - Ingmar Hoerr, CEO

观看次数1,215

人类判断

8.1
谢谢,您的投票已被记录,我们将会更新游戏评分。
视频说明

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

插件 29 Mar 2017
评论